Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Hemavant
Hemavant
Roivant to Shutter MDS-Focused ‘Vant’ After Disappointing Phase I/II Trial Results
BioSpace
Wed, 02/14/24 - 10:57 am
Roivant
TVT-2001
MDS
Hemavant
Roivant decants another Vant armed with Eisai blood cancer drug and plans to start phase 1/2 soon
Fierce Biotech
Mon, 02/14/22 - 12:05 pm
Hemavant
Roivant Sciences
Eisai
MDS
RVT-2001